The interaction of antinociceptive effects of morphine and GABA receptor agonists within the rat spinal cord

Anesthesia and Analgesia

Volumn 89, Issue 2, 1999, Pages 422-427

  Hara, Kaoru ^a   Saito, Yoji ^a   Kirihara, Yumiko ^a   Yamada, Yuko ^a   Sakura, Shinichi ^a   Kosaka, Yoshihiro ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; MORPHINE; MUSCIMOL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; COLON DILATATION; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL ANESTHESIA; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; BACLOFEN; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG SYNERGISM; GABA AGONISTS; HEAT; INJECTIONS, SPINAL; MALE; MORPHINE; MUSCIMOL; PAIN; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032784216     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199908000-00032     Document Type: Article

References (29)

1. B receptors on Aδ and C primary afferents. Br J Pharmacol 1984;81:327-33.
2. B receptors present on primary afferent terminals of spinal cord? Nature 1984;307:71-4.
3. Lin Q, Peng YB, Willis WD. Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition. J Neurophysiol 1996;75:109-23.
4. Hammond DL, Washington JD. Antagonism of L-baclofen-induced antinociception by CGP 35348 in the spinal cord of the rat. Eur J Pharmacol 1993;234:255-62.
5. Roberts LA, Beyer C, Komisaruk BR. Nociceptive responses to altered GABAergic activity at the spinal cord. Life Sci 1986;39: 1667-74.
6. Aley KO, Kulkarni SK. GABAergic agents-induced antinociceptive effects in mice. Methods Find Exp Clin Pharmacol 1989;11: 597-601.
7. Andree T, Kendall DA, Enna SJ. THIP analgesia: cross tolerance with morphine. Life Sci 1983;32:2265-72.
8. Luger TJ, Hayashi T, Weiss CG, Hill HF. The spinal potentiating effect and the supraspinal inhibitory effect of midazolam on opioid-induced analgesia in rats. Eur J Pharmacol 1995;275: 153-62.
9. 2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse. Naunyn Schmiedebergs Arch Pharmacol 1995;352:614-9.
10. Todd AJ, Spike RC, Russell G, Johnston HM. Immunohistochemical evidence that Met-enkephalin and GABA coexist in some neurons in rat dorsal horn. Brain Res 1992;584:149-56.
11. Barber RP, Vaughn JE, Saito K, et al. GABAergic terminals are presynaptic to primary afferent terminals in the substantia gelatinosa of the rat spinal cord. Brain Res 1978;141:35-55.
12. Gong L-W, Ding Y-Q, Wang D, et al. GABAergic synapses on μ-opioid receptor-expressing neurons in the superficial dorsal horn: an electron microscope study in the cat spinal cord. Neurosci Lett 1997;227:33-6.
13. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res 1988;450:153-69.
14. A receptor-mediated currents in isolated spinal dorsal horn neurons. Neurosci Lett 1994;180:109-13.
15. Carter BD, Medzihradsky F. Go mediates the coupling of the μ-opioid receptor to adenylyl cyclase in cloned neural cells and brain. Proc Natl Acad Sci USA 1993;90:4062-6.
16. A receptor current in mouse spinal neurons. Neuron 1990;5:789-96.
17. Holz GG, Rane SG, Dunlap K. GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature 1986;319:670-2.
18. b receptors to inhibition of peptide secretion from peripheral sensory neurons. J Neurosci 1989;9: 657-66.
19. Fox S, Krnjevic K, Morris ME, et al. Action of baclofen on mammalian synaptic transmission. Neuroscience 1978;3: 495-515.
20. A receptor activation, inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro. J Pharmacol Exp Ther 1993;266:1490-6.
21. Hoehn K, Reid A, Sawynok J. Pertussis toxin inhibits antinociception produced by intrathecal injection of morphine, noradrenaline and baclofen. Eur J Pharmacol 1988;146:65-72.
22. B antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen. Br J Pharmacol 1991;103: 1303-8.
23. Feldman RG, Kelly-Hayes M, Conomy JP, Foley JM. Baclofen for spasticity in multiple sclerosis. Neurology 1978;28:1094-8.
24. Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain 1992;8:338-45.
25. Dapas F, Hartman SF, Martinez L, et al. Baclofen for the treatment of acute low-back syndrome: a double-blind comparison with placebo. Spine 1985;10:345-9.
26. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984;15:240-4.
27. Terrence CF, Fromm GH, Tenicela R. Baclofen as an analgesic in chronic peripheral nerve disease. Eur Neurol 1985;24:380-5.
28. B agonist baclofen. Neuroscience 1995;69:345-9.
29. Stenseth R, Sellevold O, Breivik H. Epidural morphine for postoperative pain: experience with 1085 patients. Acta Anaesthesiol Scand 1985;29:148-56.